Compugen Ltdis A Clinical Stage Biotechnology Company Based In Holonisraelfounded In 1993The Company Specializes In Predictive Drug Discovery And Developmentfocusing On Cancer Immunotherapycompugen Employs Advanced Computational Technologiesincluding Ai And Machine Learningto Decode Tumor Biology And Identify Novel Drug Targetsenhancing The Efficiency Of Its Drug Development Pipeline The Company Collaborates With Major Pharmaceutical Firms Like Astrazeneca And Gileadleveraging These Partnerships To Advance Its Therapeutic Candidates Through Critical Development Phasescompugen S Business Model Revolves Around Target Discoveryclinical Validationand Strategic Collaborationaiming To Address Unmet Needs In Immunology And Oncologyit Is Publicly Traded On The Nasdaq Capital Market And The Tel Aviv Stock Exchange Under The Ticker Symbol Cgenreflecting Its Commitment To Research And Development In The Biotechnology Sector
